María José López-Grueso (María J López-Grueso, María José López Grueso)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Parkinson Disease

Top Venues

Antioxidants (Basel, Switzerland)

Cellular and molecular neurobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel J Lagal, María José López-Grueso, José Rafael Pedrajas, Thomas L Leto, José Antonio Bárcena Ruiz, Raquel Requejo-Aguilar, Carmen Alicia Padilla
Loss of PRDX6 Aborts Proliferative and Migratory Signaling in Hepatocarcinoma Cell Lines. Antioxidants (Basel, Switzerland) 12 (6) (2023)
Daniel J Lagal, María José López-Grueso, José Rafael Pedrajas, Thomas L Leto, José Antonio Bárcena Ruiz, Raquel Requejo-Aguilar, Carmen Alicia Padilla
Loss of PRDX6 Aborts Proliferative and Migratory Signaling in Hepatocarcinoma Cell Lines. Antioxidants (Basel, Switzerland) 12 (6) (2023)
María José López-Grueso, Carmen Alicia Padilla, José Antonio Bárcena Ruiz, Raquel Requejo-Aguilar
Deficiency of Parkinson's Related Protein DJ-1 Alters Cdk5 Signalling and Induces Neuronal Death by Aberrant Cell Cycle Re-entry. Cellular and molecular neurobiology (2022)
María José López-Grueso, Rosa María Tarradas Valero, Beatriz Carmona-Hidalgo, Daniel José Lagal Ruiz, José Peinado, Brian McDonagh, Raquel Requejo Aguilar, José Antonio Bárcena Ruiz, Carmen Alicia Padilla Peña
Peroxiredoxin 6 Down-Regulation Induces Metabolic Remodeling and Cell Cycle Arrest in HepG2 Cells. Antioxidants (Basel, Switzerland) 8 (11) (2019)
María José López-Grueso, Raúl González, Jordi Muntané, José Antonio Bárcena Ruiz, C Alicia Padilla
Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells. Antioxidants (Basel, Switzerland) 8 (10) (2019)